# Danaher vs Novo Nordisk: stocks compared

URL: https://funkfolio.com/compare/dhr-vs-nvo

> Danaher ($158.8B, P/E 37.4) and Novo Nordisk ($179.4B, P/E 10.3) compared: size, valuation, margins, debt, cash and price change.

---

## Danaher vs Novo Nordisk

Danaher (DHR), health care, and Novo Nordisk (NVO), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Novo Nordisk is worth $179.4B on the stock market and Danaher $158.8B: Novo Nordisk is valued at 13% more. Danaher trades at 37.4 times earnings and Novo Nordisk at 10.3; operating margins in their latest fiscal years were 19.1% and 41.3%. Over the past year Danaher's share price has moved +1.95% and Novo Nordisk's -12.5%.

### Key facts

- **Danaher market value:** $158.8B
- **Novo Nordisk market value:** $179.4B
- **Danaher P/E:** 37.4
- **Novo Nordisk P/E:** 10.3
- **Danaher revenue:** $24.6B FY to 2025-12-31
- **Novo Nordisk revenue:** $45.9B FY to 2025-12-31
- **Superinvestors holding both:** 2

Market values as of 18 Nov 2026, 06:57 UTC.

Danaher vs Novo Nordisk: every measure side by side

| Measure | Danaher | Novo Nordisk |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | Denmark |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $158.8B lower | $179.4B higher |
| Revenue | $24.6B lower | $45.9B higher |
| Earnings | $3.6B lower | $15.2B higher |
| Employees | 58,000 lower | 68,794 higher |
| Total assets | $83.5B higher | $80.6B lower |
| Valuation |  |  |
| P/E | 37.4 higher | 10.3 lower |
| P/S | 6.5 higher | 3.9 lower |
| P/B | 3.0 | — |
| Dividend yield | 0.66% | — |
| Profitability |  |  |
| Operating margin | 19.1% lower | 41.3% higher |
| Balance sheet |  |  |
| Net assets | $52.5B higher | $28.8B lower |
| Total liabilities | $30.9B lower | $51.8B higher |
| Total debt | $18.4B lower | $19.4B higher |
| Cash on hand | $4.6B higher | $3.9B lower |
| Price change |  |  |
| Today | -1.80% higher | -2.16% lower |
| 1 year | +1.95% higher | -12.5% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Danaher 102.4, Novo Nordisk 84.0.

- Danaher (DHR)
- Novo Nordisk (NVO)

Danaher and Novo Nordisk share prices over one year, rebased to 100: Danaher ends at 102.4, Novo Nordisk at 84.0.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | DHR | NVO |
| --- | --- | --- |
| Nov 28, 2025 | 102.9 | 101.8 |
| Dec 31, 2025 | 103.8 | 105.0 |
| Jan 30, 2026 | 99.3 | 122.6 |
| Feb 27, 2026 | 95.6 | 77.3 |
| Mar 31, 2026 | 86.0 | 75.8 |
| Apr 30, 2026 | 81.2 | 87.1 |
| May 29, 2026 | 82.9 | 94.1 |
| Jun 30, 2026 | 86.4 | 98.9 |
| Jul 31, 2026 | 88.5 | 97.2 |
| Aug 31, 2026 | 96.9 | 93.5 |
| Sep 30, 2026 | 100.5 | 78.2 |
| Oct 30, 2026 | 105.3 | 82.5 |
| Nov 17, 2026 | 102.4 | 84.0 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (2)

- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.2% / 0.4%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.3% / 0.1%

#### Danaher only (17)

- [Wallace Weitz](https://funkfolio.com/gurus/wallace-weitz) 7.0%
- [Eric Bannasch](https://funkfolio.com/gurus/eric-bannasch) 4.8%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 4.4%
- [Doug Silverman](https://funkfolio.com/gurus/doug-silverman) 2.3%
- [Dan Loeb](https://funkfolio.com/gurus/dan-loeb) 2.2%
- [Daniel Sundheim](https://funkfolio.com/gurus/daniel-sundheim) 2.1%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 1.6%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 1.5%
- [Chase Coleman](https://funkfolio.com/gurus/chase-coleman) 0.4%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.3%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.3%
- [Louis Bacon](https://funkfolio.com/gurus/louis-bacon) 0.2%
- [Stanley Druckenmiller](https://funkfolio.com/gurus/stanley-druckenmiller) 0.2%
- [Bill Gates](https://funkfolio.com/gurus/gates-foundation) 0.2%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.2%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) &lt;0.1%
- [Bill Nygren](https://funkfolio.com/gurus/bill-nygren) &lt;0.1%

#### Novo Nordisk only (6)

- [Tom Gayner](https://funkfolio.com/gurus/tom-gayner) 0.8%
- [Lee Ainslie](https://funkfolio.com/gurus/lee-ainslie) 0.7%
- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 0.6%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.4%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.2%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.2%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Danaher / Novo Nordisk). [Who owns DHR](https://funkfolio.com/stock/DHR/superinvestors) · [Who owns NVO](https://funkfolio.com/stock/NVO/superinvestors)

### More on Danaher

- [Danaher (DHR) stock page](https://funkfolio.com/stock/DHR)
- [Danaher market cap](https://funkfolio.com/stock/DHR/market-cap)
- [Danaher revenue](https://funkfolio.com/stock/DHR/revenue)
- [Danaher P/E ratio](https://funkfolio.com/stock/DHR/pe-ratio)
- [Danaher operating margin](https://funkfolio.com/stock/DHR/operating-margin)
- [Danaher total debt](https://funkfolio.com/stock/DHR/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Novo Nordisk

- [Novo Nordisk (NVO) stock page](https://funkfolio.com/stock/NVO)
- [Novo Nordisk market cap](https://funkfolio.com/stock/NVO/market-cap)
- [Novo Nordisk revenue](https://funkfolio.com/stock/NVO/revenue)
- [Novo Nordisk P/E ratio](https://funkfolio.com/stock/NVO/pe-ratio)
- [Novo Nordisk operating margin](https://funkfolio.com/stock/NVO/operating-margin)
- [Novo Nordisk total debt](https://funkfolio.com/stock/NVO/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Danaher against its closest peers

- [Danaher vs Pfizer](https://funkfolio.com/compare/dhr-vs-pfe)
- [Danaher vs Intuitive Surgical](https://funkfolio.com/compare/dhr-vs-isrg)
- [Danaher vs Abbott Laboratories](https://funkfolio.com/compare/abt-vs-dhr)

#### Novo Nordisk against its closest peers

- [Novo Nordisk vs Abbott Laboratories](https://funkfolio.com/compare/abt-vs-nvo)
- [Novo Nordisk vs Pfizer](https://funkfolio.com/compare/nvo-vs-pfe)
- [Novo Nordisk vs Intuitive Surgical](https://funkfolio.com/compare/isrg-vs-nvo)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Danaher or Novo Nordisk?**

By market value, Novo Nordisk is the larger: $179.4B against $158.8B for Danaher. By revenue in its latest fiscal year, Novo Nordisk is the larger: $45.9B against $24.6B for Danaher.

**Which has the higher P/E ratio?**

Danaher: 37.4, against 10.3 for Novo Nordisk. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Novo Nordisk: 41.3%, against 19.1% for Danaher. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has more debt?**

Novo Nordisk: $19.4B, against $18.4B for Danaher. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Danaher and Novo Nordisk?**

In their latest 13F filings, Dodge & Cox team and Ken Fisher hold both.

### Cite this page

Funkfolio, “Danaher vs Novo Nordisk”, data as of 18 November 2026. https://funkfolio.com/compare/dhr-vs-nvo

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
